Diprivan and Novolin r drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Novolin r (insulin recombinant purified human). Common drug interactions include paranoia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Novolin r. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Novolin r?

Novolin r has active ingredients of insulin recombinant purified human. It is often used in type 1 diabetes. eHealthMe is studying from 4,568 Novolin r users. Check the latest studies of Novolin r.



On Jul, 11, 2026

25 people who take Diprivan and Novolin r together, and have interactions are studied.

Diprivan and Novolin r drug interactions.

What are the common drug interactions of Diprivan and Novolin R, by gender? *:

female:

  1. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  2. Pelvic mass
  3. Post procedural hypothyroidism
  4. Proteinuria (presence of protein in the urine)
  5. Pyrexia (fever)
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
  7. Schizophrenia, paranoid type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect)
  8. Stress
  9. Suprapubic pain
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

male:

  1. Pyrexia (fever)
  2. Rash
  3. Multi-organ failure (multisystem organ failure)
  4. Myelitis transverse (a neurological condition consisting of an inflammatory process of the spinal cord)
  5. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  6. Peripheral coldness
  7. Platelet count decreased
  8. Renal failure acute (rapid kidney dysfunction)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Diprivan and Novolin R, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cholecystitis chronic (long lasting infection of gallbladder)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Fear of disease
  4. Injury
  5. Pain

40-49:

  1. Cardiac arrest
  2. Epistaxis (bleed from the nose)
  3. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  4. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  5. Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)

50-59:

  1. Suprapubic pain
  2. Thyroid adenoma (a non cancer tumour of the thyroid gland)
  3. Thyroid neoplasm (tumour of thyroid)
  4. Urinary tract infection
  5. Weight decreased
  6. Abdominal distension
  7. Abdominal pain
  8. Abdominal pain upper
  9. Adrenal mass
  10. Agitation (state of anxiety or nervous excitement)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Amylase increased
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. General physical health deterioration (weak health status)
  5. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  6. Mobility decreased (ability to move is reduced)
  7. Pyrexia (fever)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Pneumomediastinum (air is present in the mediastinum)
  10. Subcutaneous emphysema (smooth bulging of the skin)

What are the existing conditions these people have? *

  1. Pain: 11 people, 44.00%
  2. Constipation: 11 people, 44.00%
  3. High Blood Pressure: 10 people, 40.00%
  4. Pneumonia: 7 people, 28.00%
  5. Nausea (feeling of having an urge to vomit): 7 people, 28.00%
  6. Urination - Excessive Volume: 5 people, 20.00%
  7. Muscle Aches (muscle pain): 5 people, 20.00%
  8. Dehydration (dryness resulting from the removal of water): 5 people, 20.00%
  9. Haemorrhagic Diathesis (bleeding tendency): 5 people, 20.00%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Novolin r?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprivan and Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Novolin r:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Novolin r and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on propofol and insulin recombinant purified human (the active ingredients of Diprivan and Novolin r, respectively), and Diprivan and Novolin r (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: